GlassScriptPhysician profile
Sandeep Varma
NPI 1386751923
$3,026.64
in general payments reported to CMS, 2019-2025
18 companies · $1,268 in 2025
The $1,268 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $62.02 · 2021: $111 · 2022: $34.59 · 2023: $521 · 2024: $698 · 2025: $1,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,427 · Education: $59.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,426.65 |
| Education | $59.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $630.41 | 2019-2025 | Enbrel, Otezla, Otezla |
| Mallinckrodt Hospital Products INC. | $509.44 | 2021-2025 | Acthar |
| Abbvie INC. | $490.18 | 2019-2025 | Rinvoq, Humira |
| Glaxosmithkline, LLC. | $227.40 | 2019-2025 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $188.16 | 2023-2025 | Saphnelo |
| Novartis Pharmaceuticals Corporation | $151.97 | 2019-2025 | |
| Genentech USA, INC. | $122.54 | 2019-2023 | Actemra |
| E.R. Squibb & Sons, L.L.C. | $112.42 | 2024-2025 | Orencia |
| Alexion Pharmaceuticals, INC. | $104.94 | 2023-2025 | Strensiq |
| Aurinia Pharma U.S., INC. | $103.30 | 2025 | Lupkynis |
| Lilly USA, LLC | $86.03 | 2019-2025 | Zepbound, Taltz |
| Genzyme Corporation | $63.53 | 2025 | |
| Pfizer INC. | $54.99 | 2023-2025 | |
| Janssen Biotech, INC. | $54.53 | 2020-2021 | |
| Ucb, INC. | $51.08 | 2022-2025 | Bimzelx |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $29.63 | 2025 | Uptravi, Opsynvi |
| Sandoz INC. | $29.01 | 2025 | Jubbonti |
| Ani Pharmaceuticals, INC. | $17.08 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.